BR112016005225A2 - - Google Patents
Info
- Publication number
- BR112016005225A2 BR112016005225A2 BR112016005225A BR112016005225A BR112016005225A2 BR 112016005225 A2 BR112016005225 A2 BR 112016005225A2 BR 112016005225 A BR112016005225 A BR 112016005225A BR 112016005225 A BR112016005225 A BR 112016005225A BR 112016005225 A2 BR112016005225 A2 BR 112016005225A2
- Authority
- BR
- Brazil
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361876757P | 2013-09-11 | 2013-09-11 | |
US61/876,757 | 2013-09-11 | ||
PCT/US2014/055041 WO2015038682A1 (en) | 2013-09-11 | 2014-09-10 | Predicting breast cancer recurrence |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112016005225A2 true BR112016005225A2 (pt) | 2017-08-01 |
BR112016005225B1 BR112016005225B1 (pt) | 2023-11-14 |
Family
ID=52666241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112016005225-0A BR112016005225B1 (pt) | 2013-09-11 | 2014-09-10 | Métodos para avaliar câncer de mama em um indivíduo |
Country Status (10)
Country | Link |
---|---|
US (2) | US20150203921A1 (pt) |
EP (1) | EP3044335B1 (pt) |
JP (1) | JP2016536004A (pt) |
CN (1) | CN105722998A (pt) |
BR (1) | BR112016005225B1 (pt) |
CA (1) | CA2923606A1 (pt) |
ES (1) | ES2829912T3 (pt) |
IL (2) | IL244554B (pt) |
MX (2) | MX2016002938A (pt) |
WO (1) | WO2015038682A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030198972A1 (en) | 2001-12-21 | 2003-10-23 | Erlander Mark G. | Grading of breast cancer |
US9856533B2 (en) | 2003-09-19 | 2018-01-02 | Biotheranostics, Inc. | Predicting breast cancer treatment outcome |
CN103998064A (zh) | 2010-12-09 | 2014-08-20 | 生物诊断治疗公司 | 治疗后的乳腺癌预后 |
BR112018009528A2 (pt) * | 2015-11-13 | 2018-11-06 | Biotheranostics Inc | método para determinar o risco de recorrência de um câncer de mama de um sujeito, método para prever a capacidade de resposta a uma terapia de um câncer de mama de um sujeito, métodos ou tratamentos de um sujeito que tem câncer de mama que não foi tratado ou foi tratado com quimioterapia por 5 anos, métodos para recomendar o tratamento para um sujeito que tem câncer de mama, método para tratar um sujeito que tem câncer de mama |
JP2021533787A (ja) | 2018-08-17 | 2021-12-09 | ジェネンテック, インコーポレイテッド | 乳がんの処置のための診断的および治療的方法 |
CN112646890A (zh) * | 2020-12-29 | 2021-04-13 | 郑鸿钧 | 用于预测早期乳腺癌远处复发风险的多基因检测引物 |
WO2024073659A1 (en) * | 2022-09-30 | 2024-04-04 | Biotheranostics, Inc. | Biomarker assay to select breast cancer therapy |
CN117476246B (zh) * | 2023-12-25 | 2024-04-19 | 福建大数据一级开发有限公司 | 基于多类型复发事件的患者生存分析方法、介质及装置 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5545522A (en) | 1989-09-22 | 1996-08-13 | Van Gelder; Russell N. | Process for amplifying a target polynucleotide sequence using a single primer-promoter complex |
AU1820100A (en) | 1998-11-13 | 2000-06-05 | Pro Duct Health, Inc. | Devices and methods to identify ductal orifices during nipple aspiration |
US6794141B2 (en) | 2000-12-22 | 2004-09-21 | Arcturus Bioscience, Inc. | Nucleic acid amplification |
US20030198972A1 (en) | 2001-12-21 | 2003-10-23 | Erlander Mark G. | Grading of breast cancer |
US7504214B2 (en) | 2003-09-19 | 2009-03-17 | Biotheranostics, Inc. | Predicting outcome with tamoxifen in breast cancer |
BRPI0414553A (pt) | 2003-09-19 | 2006-11-07 | Arcturus Bioscience Inc | previsão do resultado de tratamento contra o cáncer de mama |
US9856533B2 (en) | 2003-09-19 | 2018-01-02 | Biotheranostics, Inc. | Predicting breast cancer treatment outcome |
JP2010538609A (ja) | 2007-09-06 | 2010-12-16 | バイオセラノスティクス,インコーポレイティド | 腫瘍グレード分類と癌の予後診断 |
HUE030164T2 (en) * | 2010-03-31 | 2017-05-29 | Sividon Diagnostics Gmbh | A method of predicting breast cancer recurrence during endocrine treatment |
CN103998064A (zh) | 2010-12-09 | 2014-08-20 | 生物诊断治疗公司 | 治疗后的乳腺癌预后 |
SG10202010758SA (en) * | 2011-11-08 | 2020-11-27 | Genomic Health Inc | Method of predicting breast cancer prognosis |
-
2014
- 2014-09-10 WO PCT/US2014/055041 patent/WO2015038682A1/en active Application Filing
- 2014-09-10 BR BR112016005225-0A patent/BR112016005225B1/pt active IP Right Grant
- 2014-09-10 ES ES14843312T patent/ES2829912T3/es active Active
- 2014-09-10 MX MX2016002938A patent/MX2016002938A/es unknown
- 2014-09-10 CN CN201480061817.8A patent/CN105722998A/zh active Pending
- 2014-09-10 EP EP14843312.1A patent/EP3044335B1/en active Active
- 2014-09-10 CA CA2923606A patent/CA2923606A1/en not_active Abandoned
- 2014-09-10 JP JP2016542081A patent/JP2016536004A/ja active Pending
- 2014-09-10 US US14/483,108 patent/US20150203921A1/en not_active Abandoned
-
2016
- 2016-03-04 MX MX2021002014A patent/MX2021002014A/es unknown
- 2016-03-10 IL IL244554A patent/IL244554B/en active IP Right Grant
-
2020
- 2020-08-05 IL IL276505A patent/IL276505B/en unknown
-
2021
- 2021-10-28 US US17/513,640 patent/US20220186317A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2829912T3 (es) | 2021-06-02 |
CA2923606A1 (en) | 2015-03-19 |
IL244554B (en) | 2020-08-31 |
IL276505A (en) | 2020-09-30 |
EP3044335A4 (en) | 2017-04-19 |
MX2016002938A (es) | 2016-07-26 |
CN105722998A (zh) | 2016-06-29 |
JP2016536004A (ja) | 2016-11-24 |
US20150203921A1 (en) | 2015-07-23 |
EP3044335A1 (en) | 2016-07-20 |
WO2015038682A1 (en) | 2015-03-19 |
IL276505B (en) | 2022-03-01 |
IL244554A0 (en) | 2016-04-21 |
EP3044335B1 (en) | 2020-09-09 |
BR112016005225B1 (pt) | 2023-11-14 |
MX2021002014A (es) | 2021-04-28 |
US20220186317A1 (en) | 2022-06-16 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/09/2014, OBSERVADAS AS CONDICOES LEGAIS |